Larotrectinib Does Not Increase Risk of Fractures for Thyroid CancerByTheodore W. Laetsch, MDMarch 23rd 2022Theodore W. Laetsch, MD, discusses various trials examining larotrectinib in patients with TRK fusion positive thyroid cancer.